AppTail AppTail.

MyFibroScan

Published by: ECHOSENS
View in Store
Unlock
Downloads
Unlock
Revenue

Description

FibroScan® is the non-invasive solution for comprehensive management of liver health.

Fibroscan® provides unique and patented biomarkers, LSM by VCTE™ (Liver Stiffness Measurement) and CAP™ (Controlled Attenuation Parameter) that benefit from a worldwide clinical evidence with over 2500 peer-reviewed publications and 60+ international guidelines.

myFibroScan app is your everyday FibroScan® companion to access Interpretation Guide and FibroScan® based scores in an easy, fast and intuitive way :

The Interpretation Guide utilizes data from clinical studies to assist providers in interpreting Fibroscan® examination results.
Scores enhance Fibroscan® liver disease assessment with biological markers.
Scores are presented as educational services intended for licensed healthcare professionals. While the scores are about specific medical and healthcare issues, they are not a substitute for/or replacement of personalized medical advice and are not intended to be used as the sole basis for making individualized medical or health-related decisions.

- Agile™3+ is an aid to identify NAFLD patients with advanced fibrosis by combining VCTE™ and routine clinical parameters to reduce the need for liver biopsy. High clinical performances are demonstrated in large external validation cohorts from different geographical origins.

- Agile™4 is an aid to early identify NAFLD patients with cirrhosis by combining VCTE™ and routine clinical parameters. It can help the physicians to manage the disease to prevent liver-related complications such as hepatocellular carcinoma. High clinical performances are demonstrated in large external validation cohorts from different geographical origin.

- Fast™ is an aid to identify at risk NASH patients defined as NASH + NAS≥4 + F≥2. Good to excellent performance in cohorts from different clinical settings (NAFLD tertiary care unit, screening, bariatric surgery) and geographical origins (USA, Europe, Asia). Several publications advocate the use of Fast™.
Hide Show More...

Screenshots

MyFibroScan FAQ

  • Is MyFibroScan free?

    Yes, MyFibroScan is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is MyFibroScan legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does MyFibroScan cost?

    MyFibroScan is free.

  • What is MyFibroScan revenue?

    To get estimated revenue of MyFibroScan app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Pakistan yet.
View ratings in United States
Ratings History

MyFibroScan Reviews

Buggy / Account won’t validate

Nickname 20,000 on

United States

App is buggy and unable to send me an email to validate my account so I can use it. It will however successfully send an message for password reset so the issue is not an incorrect email address. I’ve wasted over an hour on trying to get it to work.

Show More

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
Chart
Category
Rank
Top Free
Ecuador Medical
250

MyFibroScan Competitors

Name
ECCO IBD
The App for the IBD Community
COVID-19 iChart
COVID-19 drug interactions
ClinicalKey
ESC CVD Risk Calculation
For healthcare professionals
ONCOassist
The go-to app in oncology
GI Guidelines
ESPEN Guidelines
GHAPP ACE
EASL Congress 2024
EASL Guidelines
EASL
Show More

MyFibroScan Installs

Last 30 days

-1

View Installs Data

MyFibroScan Revenue

Last 30 days

$-1

View Revenue Data

MyFibroScan Revenue and Downloads

Gain valuable insights into MyFibroScan performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

Category
Medical
Publisher
ECHOSENS
Languages
English
Recent release
2.4.0 (8 months ago )
Released on
Apr 16, 2017 (7 years ago )
Also available in
United States , Argentina , France , Taiwan , Brazil , Mexico , Russia , United Kingdom , Japan , Netherlands , Chile , Hungary , New Zealand , Poland , Nepal , Norway , Nigeria , Malaysia , Malta , Latvia , Luxembourg , Lithuania , Sri Lanka , Peru , Philippines , Pakistan , South Africa , Portugal , Romania , Saudi Arabia , Sweden , Singapore , Slovenia , Slovakia , Thailand , Tunisia , Türkiye , Vietnam , United Arab Emirates , Algeria , Armenia , Austria , Australia , Azerbaijan , Belgium , Bulgaria , Bahrain , Belarus , Canada , Switzerland , Colombia , Czechia , Germany , Denmark , Dominican Republic , Lebanon , Ecuador , Estonia , Egypt , Finland , Greece , Hong Kong SAR China , Croatia , Indonesia , Ireland , Israel , India , Italy , Kuwait , Kazakhstan
Last Updated
1 week ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.
AppTail.

Product

Resources

Contact